ACU-4492 News
Most Popular ACU-4492 Story
Acucela inks dev. deal for two compounds
Bothell, WA-based Acucela has inked co-development deals for two of its eye therapies with Japan's Otsuka Pharmaceuticals. One pact covers the development of ACU-4429 for dry AMD and the late-stage Read more...
Latest Headlines
- September 4, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
